Market research
SIGA SIGA Technologies Inc
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 218M
- P/E ratio
- Not available
- Analyst target
- 17.53
- Dividend yield
- 0.0%
- Beta
- 0.89
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- US8269171067
- Market cap
- 218M
- P/E ratio
- Not available
- Analyst target
- 17.53
- Dividend yield
- 0.0%
- Beta
- 0.89
About
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SIGA discussion.
5 years, 4 months ago
SIGA Technologies, Inc is currently in a long term downtrend where the price is trading 14.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
SIGA Technologies, Inc's total revenue rose by 784.8% to $38M since the same quarter in the previous year.
Its net income has increased by 547.8% to $20M since the same quarter in the previous year.
Finally, its free cash flow grew by 422.1% to $46M since the same quarter in the previous year.
Based on the above factors, SIGA Technologies, Inc gets an overall score of 4/5.